Related Experiment Videos
Expression of adhesion molecules in poststreptococcal glomerulonephritis
G Parra1, M Romero, C Henriquez-La Roche
1Renal Service and Laboratory, Hospital Universitario de Maracaibo, Venezuela.
Summary
Increased expression of intercellular adhesion molecule 1 (ICAM-1) and lymphocyte-function-associated antigen 1 (LFA-1) was observed in kidney biopsies of Post-Streptococcal Glomerulonephritis (PSGN) patients. These adhesion molecules are likely involved in the inflammatory infiltration characteristic of PSGN.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Leukocyte adhesion is crucial for inflammatory cell infiltration and localization.
- Understanding adhesion molecule expression in kidney diseases like Post-Streptococcal Glomerulonephritis (PSGN) is vital.
Purpose of the Study:
- To investigate the expression of key adhesion molecules (ICAM-1, LFA-1, VCAM-1) in kidney biopsies from PSGN patients.
- To determine if expression levels correlate with disease stage (early vs. late PSGN).
Main Methods:
- Analysis of 14 kidney biopsies from PSGN patients, categorized into early (<15 days) and late (17-90 days) stages.
- Quantification of intercellular adhesion molecule 1 (ICAM-1) and lymphocyte-function-associated antigen 1 (LFA-1) expression in glomeruli and interstitium.
- Comparison with normal kidney tissue controls.
Main Results:
- Intraglomerular ICAM-1 expression was significantly elevated in early PSGN biopsies and decreased over time.
- Interstitial ICAM-1 levels were increased in both early and late PSGN compared to normal kidneys.
- LFA-1 positive cells were significantly increased in glomeruli and interstitium of early PSGN biopsies.
- No significant increase in VCAM-1 expression was observed in PSGN kidneys.
Conclusions:
- Adhesion molecules ICAM-1 and LFA-1 show increased expression in the kidneys of PSGN patients, particularly in the early disease phase.
- These findings suggest a significant role for ICAM-1 and LFA-1 in the inflammatory cell infiltration observed in PSGN.
- Targeting these adhesion molecules may offer therapeutic potential for managing PSGN-related inflammation.